DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Proteomic Profile Associated With Loss of Spontaneous Human Immunodeficiency Virus Type 1 Elite Control
[Background] Elite controllers (ECs) spontaneously control plasma human immunodeficiency virus type 1 (HIV-1) RNA without antiretroviral therapy. However, 25% lose virological control over time. The aim of this work was to study the proteomic profile that preceded this loss of virological control to identify potential biomarkers., [Methods] Plasma samples from ECs who spontaneously lost virological control (transient controllers [TCs]), at 2 years and 1 year before the loss of control, were compared with a control group of ECs who persistently maintained virological control during the same follow-up period (persistent controllers [PCs]). Comparative plasma shotgun proteomics was performed with tandem mass tag (TMT) isobaric tag labeling and nanoflow liquid chromatography coupled to Orbitrap mass spectrometry., [Results] Eighteen proteins exhibited differences comparing PC and preloss TC timepoints. These proteins were involved in proinflammatory mechanisms, and some of them play a role in HIV-1 replication and pathogenesis and interact with structural viral proteins. Coagulation factor XI, α-1-antichymotrypsin, ficolin-2, 14-3-3 protein, and galectin-3-binding protein were considered potential biomarkers., [Conclusions] The proteomic signature associated with the spontaneous loss of virological control was characterized by higher levels of inflammation, transendothelial migration, and coagulation. Galectin-3 binding protein could be considered as potential biomarker for the prediction of virological progression and as therapeutic target in ECs., This work was supported by grants from the Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Fondos Europeos para el Desarrollo Regional (grant numbers PI10/02635, PI13/00796, and PI16/00503 to F. V.; PI12/02283, PI16/00684, and CPII014/00025 to E. R.-M.; FI14/00431 to L. T.-D.; and CP14/00198 to N. R.); Programa de Suport als Grups de Recerca (grant numbers 2017SGR948 and 2014SGR250); the Gilead Fellowship Program (grant numbers GLD14/293 and GLD17/00299); the Red de Investigación en Sida (grant numbers RD12/0017/0005, RD16/0025/0006, RD12/0017/0029, RD16/0025/0020, and RD12/0017/0031, RD16/0025/0013); Ministerio de Economia y Competitividad, Spain (grant number SAF2015-66193-R); and the Spanish Ministry of Education (grant number FPU13/02451 to B. D. M). E. R.-M. is supported by Consejería de Salud y Bienestar Social of Junta de Andalucía through the Nicolás Monardes program (C-0032/17). F. V. is supported by a grant from the Programa de Intensificación de Investigadores, Instituto de Salud Carlos III (grant numbers INT11/240, INT12/282, and INT15/226). A. R. is supported by a grant from the Acció Instrumental d’incorporació de científics i tecnòlegs (PERIS SLT002/16/00101), Departament de Salut, Generalitat de Catalunya., Peer reviewed